Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 534

1.

Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study.

Mahmoodi BK, Brouwer JL, Veeger NJ, van der Meer J.

Circulation. 2008 Oct 14;118(16):1659-67. doi: 10.1161/CIRCULATIONAHA.108.780759. Epub 2008 Sep 29.

2.

High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.

Brouwer JL, Lijfering WM, Ten Kate MK, Kluin-Nelemans HC, Veeger NJ, van der Meer J.

Thromb Haemost. 2009 Jan;101(1):93-9.

PMID:
19132194
3.

The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study.

Sanson BJ, Simioni P, Tormene D, Moia M, Friederich PW, Huisman MV, Prandoni P, Bura A, Rejto L, Wells P, Mannucci PM, Girolami A, Büller HR, Prins MH.

Blood. 1999 Dec 1;94(11):3702-6.

4.
5.

Protein S type III deficiency is no risk factor for venous and arterial thromboembolism in 168 thrombophilic families: a retrospective study.

Libourel EJ, Bank I, Veeger NJ, Hamulyàk K, Middeldorp S, Prins MH, Büller HR, van der Meer J.

Blood Coagul Fibrinolysis. 2005 Mar;16(2):135-40.

PMID:
15741801
6.

Incidence of venous thromboembolism in families with inherited thrombophilia.

Simioni P, Sanson BJ, Prandoni P, Tormene D, Friederich PW, Girolami B, Gavasso S, Huisman MV, Büller HR, Wouter ten Cate J, Girolami A, Prins MH.

Thromb Haemost. 1999 Feb;81(2):198-202.

PMID:
10063991
7.

Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study.

van Vlijmen EF, Brouwer JL, Veeger NJ, Eskes TK, de Graeff PA, van der Meer J.

Arch Intern Med. 2007 Feb 12;167(3):282-9.

PMID:
17296885
8.

The pathogenesis of venous thromboembolism: evidence for multiple interrelated causes.

Brouwer JL, Veeger NJ, Kluin-Nelemans HC, van der Meer J.

Ann Intern Med. 2006 Dec 5;145(11):807-15.

PMID:
17146065
9.

Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives.

Lijfering WM, Brouwer JL, Veeger NJ, Bank I, Coppens M, Middeldorp S, Hamulyák K, Prins MH, Büller HR, van der Meer J.

Blood. 2009 May 21;113(21):5314-22. doi: 10.1182/blood-2008-10-184879. Epub 2009 Jan 12.

10.

Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis.

Friederich PW, Sanson BJ, Simioni P, Zanardi S, Huisman MV, Kindt I, Prandoni P, Büller HR, Girolami A, Prins MH.

Ann Intern Med. 1996 Dec 15;125(12):955-60. Erratum in: Ann Intern Med 1997 May 15;126(10):835. Ann Intern Med 1997 Dec 15;127(12):1138.

PMID:
8967705
11.

Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood.

Nowak-Göttl U, Junker R, Hartmeier M, Koch HG, Münchow N, Assmann G, von Eckardstein A.

Circulation. 1999 Aug 17;100(7):743-8.

12.

High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study.

Mahmoodi BK, ten Kate MK, Waanders F, Veeger NJ, Brouwer JL, Vogt L, Navis G, van der Meer J.

Circulation. 2008 Jan 15;117(2):224-30. Epub 2007 Dec 24.

13.

Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study.

Bucciarelli P, Rosendaal FR, Tripodi A, Mannucci PM, De Stefano V, Palareti G, Finazzi G, Baudo F, Quintavalla R.

Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):1026-33.

14.

Gene-gene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiency.

van Boven HH, Vandenbroucke JP, Briët E, Rosendaal FR.

Blood. 1999 Oct 15;94(8):2590-4.

15.

Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?

Linnemann B, Schindewolf M, Zgouras D, Erbe M, Jarosch-Preusche M, Lindhoff-Last E.

Thromb Res. 2008;121(6):743-50. Epub 2007 Sep 4.

PMID:
17804043
16.

Recurrence of venous thromboembolism in patients with familial thrombophilia.

van den Belt AG, Sanson BJ, Simioni P, Prandoni P, Büller HR, Girolami A, Prins MH.

Arch Intern Med. 1997 Oct 27;157(19):2227-32. Review.

PMID:
9342999
17.
18.

High risk of pregnancy-related venous thromboembolism in women with multiple thrombophilic defects.

Folkeringa N, Brouwer JL, Korteweg FJ, Veeger NJ, Erwich JJ, van der Meer J.

Br J Haematol. 2007 Jul;138(1):110-6.

PMID:
17555454
19.

Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.

Folkeringa N, Coppens M, Veeger NJ, Bom VJ, Middeldorp S, Hamulyak K, Prins MH, Büller HR, van der Meer J.

Thromb Haemost. 2008 Jul;100(1):38-44. doi: 10.1160/TH07-11-0659.

PMID:
18612536

Supplemental Content

Support Center